In addition, the overexpression of TR3 upregulated the expression of genes that are involved in cell proliferation, migration, invasion, angiogenesis, and pathways in cancer as well as PI3K/AKT and MAPK/ERK signaling pathways that are amplified as prostate cancer progresses into CRPC. This evidence concerns the gene AKT1 and prostate carcinoma.